Taylor Morrison Home Corporation (TMHC) P/E Ratio History
ExpensiveTrading at 9.2x vs 5Y avg 6.5x · 95th percentile · Material premium to history · Data 2013–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Taylor Morrison Home Corporation (TMHC) trades at a price-to-earnings ratio of 9.2x, with a stock price of $71.58 and trailing twelve-month earnings per share of $6.89.
The current P/E is 42% above its 5-year average of 6.5x. Over the past five years, TMHC's P/E has ranged from a low of 2.6x to a high of 9.3x, placing the current valuation at the 95th percentile of its historical range.
Compared to the Consumer Cyclical sector median P/E of 21.2x, TMHC trades at a 56% discount to its sector peers. The sector includes 307 companies with P/E ratios ranging from 0.1x to 184.9x.
The PEG ratio of 0.28 (P/E divided by -6% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, TMHC trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TMHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TMHC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
TMHC P/E vs Peers
Luxury and move-up homebuilders peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $46B | 13.6 | 1.09 | -19% | |
| $22B | 11.2 | - | -44% | |
| $24B | 11.4 | 0.69 | -24% | |
| $15B | 11.5 | 0.36Best | -10% | |
| $18B | 14.9 | 1.09 | -14% | |
| $4B | 10.1 | 0.82 | -25% | |
| $3B | 8.8Lowest | 0.61 | -27% | |
| $4B | 17.3 | 3.74 | -44% | |
| $5B | 25.1 | 1.05 | +16%Best | |
| $5B | 22.8 | 1.16 | +7% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
TMHC Historical P/E Data (2013–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $58.24 | $6.70 | 8.7x | -5% |
| FY2025 Q4 | Dec 31 2025 | $58.87 | $7.76 | 7.6x | -17% |
| FY2025 Q3 | - | $66.01 | $8.29 | 8.0x | -13% |
| FY2025 Q2 | Jun 30 2025 | $61.42 | $8.65 | 7.1x | -23% |
| FY2025 Q1 | Mar 31 2025 | $60.04 | $8.59 | 7.0x | -24% |
| FY2024 Q4 | - | $61.21 | $8.27 | 7.4x | -19% |
| FY2024 Q3 | Sep 30 2024 | $70.26 | $7.56 | 9.3x | +1% |
| FY2024 Q2 | Jun 30 2024 | $55.44 | $6.73 | 8.2x | -10% |
| FY2024 Q1 | Mar 31 2024 | $62.17 | $6.99 | 8.9x | -3% |
| FY2023 Q4 | Dec 31 2023 | $53.35 | $6.98 | 7.6x | -17% |
| FY2023 Q3 | Sep 30 2023 | $42.61 | $7.91 | 5.4x | -41% |
| FY2023 Q2 | Jun 30 2023 | $48.77 | $9.09 | 5.4x | -42% |
| FY2023 Q1 | Mar 31 2023 | $38.26 | $9.42 | 4.1x | -56% |
| FY2022 Q4 | Dec 31 2022 | $30.35 | $9.12 | 3.3x | -64% |
| FY2022 Q3 | Sep 30 2022 | $23.32 | $8.80 | 2.6x | -71% |
| FY2022 Q2 | - | $23.36 | $7.42 | 3.1x | -66% |
| FY2022 Q1 | - | $27.22 | $5.92 | 4.6x | -50% |
| FY2021 Q4 | Dec 31 2021 | $34.96 | $5.23 | 6.7x | -27% |
| FY2021 Q3 | - | $25.78 | $3.76 | 6.9x | -25% |
| FY2021 Q2 | Jun 30 2021 | $26.42 | $3.29 | 8.0x | -13% |
| FY2021 Q1 | Mar 31 2021 | $30.81 | $2.84 | 10.8x | +18% |
| FY2020 Q4 | - | $25.65 | $1.83 | 14.0x | +53% |
| FY2020 Q3 | Sep 30 2020 | $24.59 | $1.62 | 15.2x | +65% |
| FY2020 Q2 | - | $19.29 | $1.38 | 14.0x | +52% |
| FY2020 Q1 | - | $11.00 | $1.64 | 6.7x | -27% |
| FY2019 Q4 | - | $21.86 | $2.36 | 9.3x | +1% |
| FY2019 Q3 | Sep 30 2019 | $25.94 | $1.93 | 13.4x | +46% |
| FY2019 Q2 | Jun 30 2019 | $20.96 | $2.13 | 9.8x | +7% |
| FY2019 Q1 | Mar 31 2019 | $17.75 | $1.89 | 9.4x | +2% |
| FY2018 Q4 | Dec 31 2018 | $15.90 | $1.84 | 8.6x | -6% |
| FY2018 Q3 | Sep 30 2018 | $18.04 | $2.02 | 8.9x | -3% |
| FY2018 Q2 | Jun 30 2018 | $20.78 | $1.64 | 12.7x | +38% |
| FY2018 Q1 | Mar 31 2018 | $23.28 | $1.58 | 14.7x | +60% |
| FY2017 Q4 | Dec 31 2017 | $24.47 | $1.47 | 16.6x | +81% |
| FY2017 Q3 | Sep 30 2017 | $22.05 | $1.84 | 12.0x | +30% |
| FY2017 Q2 | Jun 30 2017 | $24.01 | $1.88 | 12.8x | +39% |
| FY2017 Q1 | Mar 31 2017 | $21.32 | $1.79 | 11.9x | +30% |
| FY2016 Q4 | Dec 31 2016 | $19.26 | $1.70 | 11.3x | +23% |
| FY2016 Q3 | Sep 30 2016 | $17.60 | $1.61 | 10.9x | +19% |
| FY2016 Q2 | - | $14.84 | $1.49 | 10.0x | +8% |
| FY2016 Q1 | - | $14.12 | $1.27 | 11.1x | +21% |
| FY2015 Q4 | - | $16.00 | $1.85 | 8.6x | -6% |
| FY2015 Q3 | Sep 30 2015 | $18.66 | $2.15 | 8.7x | -5% |
| FY2015 Q2 | - | $20.36 | $2.32 | 8.8x | -4% |
| FY2015 Q1 | - | $20.85 | $2.62 | 8.0x | -13% |
| FY2014 Q4 | Dec 31 2014 | $18.89 | $2.16 | 8.7x | -5% |
| FY2014 Q3 | - | $16.22 | $2.11 | 7.7x | -16% |
| FY2014 Q2 | Jun 30 2014 | $22.42 | $2.00 | 11.2x | +22% |
| FY2014 Q1 | Mar 31 2014 | $23.50 | $1.71 | 13.7x | +50% |
| FY2013 Q4 | - | $22.45 | $1.58 | 14.2x | +55% |
| FY2013 Q3 | Sep 30 2013 | $22.65 | $3.64 | 6.2x | -32% |
| FY2013 Q2 | Jun 30 2013 | $24.38 | $3.27 | 7.5x | -19% |
Average P/E for displayed period: 9.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TMHC — Frequently Asked Questions
Quick answers to the most common questions about buying TMHC stock.
What is TMHC's P/E ratio?
Taylor Morrison Home Corporation (TMHC) trailing twelve-month P/E ratio is 9.2x, based on TTM diluted EPS of $6.89. The 5-year average P/E is 6.5x and the historical range spans 2.6x to 9.3x.
Is TMHC stock overvalued or undervalued?
TMHC trades at 9.2x P/E, above its 5-year average of 6.5x. The 95th percentile ranking within the 2.6x–9.3x historical range indicates a premium to historical valuation.
Is TMHC stock expensive?
Yes, TMHC is expensive relative to its own history. The current P/E of 9.2x is above the 5-year average of 6.5x. The stock sits at the 95th percentile of its 5-year valuation range.
What is TMHC's historical P/E range?
Over the past 5 years, TMHC's P/E ratio has ranged from 2.6x to 9.3x, with a median of 7.1x and an average of 6.5x. The current P/E of 9.2x places the stock at the 95th percentile of this range. Full historical data spans 2013–2026.
How does TMHC's P/E compare to the S&P 500?
TMHC trades at 9.2x P/E versus the S&P 500 median of 24.4x. The 62% discount to the market suggests lower growth expectations or perceived higher risk.
How does TMHC's valuation compare to Consumer Cyclical peers?
Taylor Morrison Home Corporation P/E of 9.2x compares to the Consumer Cyclical sector median of 21.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is TMHC's PEG ratio?
TMHC PEG ratio is 0.28, based on a P/E of 9.2x and EPS growth of -6.0%. A PEG below 1.0 indicates the valuation is supported by the earnings growth rate — typically considered attractive.
What is TMHC's earnings yield?
TMHC earnings yield is 10.85%, the inverse of its 9.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.